Compared with cotrimoxazole nitroxoline seems to be a better option for the treatment and prophylaxis of urinary tract infections caused by multidrug-resistant uropathogens. An in vitro study - Dobrindt, U; Wami, HT; Schmidt-Wieland, T (Antibiotics (Basel), 2021)
et al.